Key Insights

Highlights

Success Rate

86% trial completion

Published Results

33 trials with published results (17%)

Research Maturity

95 completed trials (48% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

8.0%

16 terminated out of 199 trials

Success Rate

85.6%

-0.9% vs benchmark

Late-Stage Pipeline

24%

47 trials in Phase 3/4

Results Transparency

35%

33 of 95 completed with results

Key Signals

33 with results86% success16 terminated

Data Visualizations

Phase Distribution

134Total
Not Applicable (47)
Early P 1 (2)
P 1 (19)
P 2 (19)
P 3 (8)
P 4 (39)

Trial Status

Completed95
Recruiting41
Terminated16
Not Yet Recruiting16
Unknown14
Withdrawn8

Trial Success Rate

85.6%

Benchmark: 86.5%

Based on 95 completed trials

Clinical Trials (199)

Showing 20 of 20 trials
NCT03726307Phase 1Active Not RecruitingPrimary

Allogeneic Regulatory Dendritic Cell (DCreg) Renal Study

NCT05557370Phase 4Active Not Recruiting

Immunogenicity of HPV Vaccine in Transplant Recipients.

NCT07551531Not Yet RecruitingPrimary

GraftAssure Lowering Allograft rejeCTIon by Combination- (GALACTIC) Trial

NCT07555106Phase 2Active Not RecruitingPrimary

Dapagliflozin in Living-Donor Kidney Transplant Recipients

NCT06830798Phase 3Recruiting

Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation

NCT04969757Not ApplicableCompletedPrimary

Use of Predigraft in Kidney Transplant Patients

NCT06013865Phase 4RecruitingPrimary

Empagliflozin Treatment in Kidney Transplant Recipients

NCT06044493Phase 4CompletedPrimary

MYREPTIC-N® or MY-REPT® in Stable Patients After Kidney Transplant Recipients

NCT04102943Phase 4CompletedPrimary

Study to Evaluate the Pharmacokinetics and Tolerability of Tacrolimus in Kidney Transplant Recipients.

NCT07532382RecruitingPrimary

Personalized Stories for Pediatric Kidney Recipients

NCT06288152Not ApplicableRecruiting

Evaluation of Thiosulfate Enhanced Organ Preservation Solution in Kidney Transplantation

NCT06833463RecruitingPrimary

Tacrolimus and Risk Factors for Glucose Metabolism Disorders in Kidney Transplant Patients

NCT07348458Not ApplicableRecruitingPrimary

Kidney Protective Jacket

NCT05917522Phase 2RecruitingPrimary

Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation

NCT06832410Phase 3Recruiting

An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant

NCT06953336Not ApplicableCompleted

Vouchers for Improving Transplant Access to Lifestyle Nutrition - Kidney Transplant

NCT02986243Not ApplicableActive Not RecruitingPrimary

Preparing for Kidney Transplant by Attaining a Healthy Weight

NCT06472947RecruitingPrimary

Non-invasive Evaluation of Graft Condition in Adult Patients With Kidney Transplant Using Ultrasound Localization Microscopy and Multispectral Optoacoustic Tomography

NCT06055608Phase 2RecruitingPrimary

Advancing Transplantation Outcomes in Children

NCT07436338CompletedPrimary

ABO- or HLA- Incompatible LDKT Compared to Waitlist/DDKT in Elderly Patients

Scroll to load more

Research Network

Activity Timeline